Biotech Blog Archives: February 2005
·
previous page
15 February 2005
More Roadblocks Ahead For Pharma in 2005?
The pharmaceutical industry was traumatized in 2004 when Merck had to withdraw its $2.5 billion COX-2 inhibitor Vioxx from the market due to potentially lethal side effects. Pharmaceutical companies are already struggling to deal with increasing generic competition and stringent approval standards in an effective manner. Will the aftereffects of a disastrous 2004 [...]
continue reading... » 0 Comments
10 February 2005
Genetically Modified IP Launched
Genetically Modified IP Launched
A paper appearing in this week’s edition of Nature is antiseptically entitled: ‘Gene transfer to plants by diverse species of bacteria.’ But the information that lies within may herald a revolution in biology.
continue reading... » 0 Comments
8 February 2005
From the laboratory to the investment fund
From the laboratory to the investment fund
How two Chilean scientists turned a graduate thesis into a business that is helping salmon and ham producers
continue reading... » 0 Comments
7 February 2005
Biotech: A Big Future Behind It?
Biotech: A Big Future Behind It?
Despite a bumpy 2004, the rush to market hasn’t abated. The key for this crop of newcomers: Holding investors’ attention?
continue reading... » 0 Comments
3 February 2005
The State of Stem Cell Research
The State of Stem Cell Research
Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan
continue reading... » 0 Comments
2 February 2005
The Human Genome, Take Two
The Human Genome, Take Two
When a sequenced human genome was announced in 2001, most people missed a crucial part of the news: the genome was a first draft, sketchy and incomplete. This fall, scientists completed a new draft. The more complete version reveals that humans have a few thousand fewer genes than was previously predicted. [...]
